Last 12 months
Inside the activity.
15 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 4 | 0 |
| Oct 2026 | 3 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2021 Filed Jun 29, 2021 18:13 UTC |
HENNEY CHRISTOPHER SDirector
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 12,000 | $16.43 | $197,160.00 |
DisclosureSEC source: 0001567619-21-012739 · doc1.xml · nonDerivative · entry 1 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 81,250 | $0.00 Strike: $15.04 | $0.00 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · derivative · entry 10 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Underlying: Ordinary Shares · 81,250 shares Expires 2028-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $27.81 | $0.00 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · derivative · entry 9 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 19,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: The shares subject to the option were fully vested as of the date of the exercise. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $20.17 | $0.00 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · derivative · entry 8 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2023-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: The shares subject to the option were fully vested as of the date of the exercise. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 5,203 | $49.01 | $254,985.50 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 7 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $48.31 to $49.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 18,101 | $47.81 | $865,497.50 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 6 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,203 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $47.31 to $48.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 26,106 | $46.27 | $1,208,036.88 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 5 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,304 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $46.03 to $46.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 65,840 | $45.42 | $2,990,248.70 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 4 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,410 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $45.015 to $46.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 81,250 | $15.04 | $1,222,000.00 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 3 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 19,000 | $27.81 | $528,390.00 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 2 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:38 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 15,000 | $20.17 | $302,550.00 |
DisclosureSEC source: 0001567619-21-012571 · doc1.xml · nonDerivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 21:05 UTC |
EcoR1 Capital, LLC10% owner
|
OtherCall Option (Right to Purchase) · Derivative | 2,500 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012482 · doc1.xml · derivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 0 Underlying: Ordinary Shares · 250,000 shares Expires 2021-06-18 F2 · kind: On June 18, 2021, the Filers exercised 2,500 call options to acquire 250,000 Ordinary Shares. Qualified Fund exercised 2,099 of those call options to acquire 209,900 Ordinary Shares. After this transaction, Qualified Fund owned 9,485,116 Ordinary Shares. F2 · shares: On June 18, 2021, the Filers exercised 2,500 call options to acquire 250,000 Ordinary Shares. Qualified Fund exercised 2,099 of those call options to acquire 209,900 Ordinary Shares. After this transaction, Qualified Fund owned 9,485,116 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 21:05 UTC |
EcoR1 Capital, LLC10% owner
|
OtherOrdinary Shares | 250,000 | $30.00 | $7,500,000.00 |
DisclosureSEC source: 0001567619-21-012482 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 11,284,280 F2 · kind: On June 18, 2021, the Filers exercised 2,500 call options to acquire 250,000 Ordinary Shares. Qualified Fund exercised 2,099 of those call options to acquire 209,900 Ordinary Shares. After this transaction, Qualified Fund owned 9,485,116 Ordinary Shares. F2 · shares: On June 18, 2021, the Filers exercised 2,500 call options to acquire 250,000 Ordinary Shares. Qualified Fund exercised 2,099 of those call options to acquire 209,900 Ordinary Shares. After this transaction, Qualified Fund owned 9,485,116 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:05 UTC |
Patel SanjivDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010961 · doc1.xml · derivative · entry 1 Patel Sanjiv · CIK 0001816210 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 33 1/3% of the total number of shares subject to the option on the first anniversary of the grant date, 33 1/3% on the second anniversary of the grant date, and the remaining 33 1/3% on the earlier of the third anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous services as a director until each such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:05 UTC |
COLLIER RICHARD TDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010960 · doc1.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 17:02 UTC |
HENNEY CHRISTOPHER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010951 · doc1.xml · derivative · entry 1 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:03 UTC |
Ekman LarsDirector · Chairman of the Board
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010955 · doc1.xml · derivative · entry 1 Ekman Lars · CIK 0001376117 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:06 UTC |
Cooke ShaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010962 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:03 UTC |
Selkoe Dennis J.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010953 · doc1.xml · derivative · entry 1 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:04 UTC |
Cobb Paula KDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010957 · doc1.xml · derivative · entry 1 Cobb Paula K · CIK 0001763372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:02 UTC |
Harfstrand Karl Anders OlofDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010949 · doc1.xml · derivative · entry 1 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 17:41 UTC |
Garren HidekiChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $24.90 | $0.00 |
DisclosureSEC source: 0001567619-21-007776 · doc1.xml · derivative · entry 1 Garren Hideki · CIK 0001854126 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Ordinary Shares · 250,000 shares Expires 2031-04-05 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 15:14 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 875,000 | $20.75 | $18,156,250.00 |
DisclosureSEC source: 0001567619-21-006927 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 11,034,280 F2 · shares: Qualified Fund purchased 746,500 of the Ordinary Shares purchased in this transaction. After this transaction, Qualified Fund owned 9,275,216 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:14 UTC |
Smith Brandon S.Chief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005089 · doc1.xml · derivative · entry 1 Smith Brandon S. · CIK 0001805226 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 56,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:08 UTC |
Zago Wagner M.Chief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005077 · doc1.xml · derivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 56,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 17:10 UTC |
Karp Carol D.Chief Regulatory Officer
|
GrantStock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005082 · doc1.xml · derivative · entry 1 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 56,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:14 UTC |
Nguyen TranSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005091 · doc1.xml · derivative · entry 1 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Ordinary Shares · 84,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:13 UTC |
Kinney Gene G.President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-21-005088 · doc1.xml · derivative · entry 2 Kinney Gene G. · CIK 0001564380 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2030-02-25 F2 · derivative.exercise_date: On February 25, 2020, the reporting person was granted an option to purchase 50,000 ordinary shares. The shares subject to the option vested in full based on the achievement of certain performance criteria. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:13 UTC |
Kinney Gene G.President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005088 · doc1.xml · derivative · entry 1 Kinney Gene G. · CIK 0001564380 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Ordinary Shares · 250,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:12 UTC |
Tripuraneni RadhikaChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005085 · doc1.xml · derivative · entry 1 Tripuraneni Radhika · CIK 0001761114 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 56,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:11 UTC |
Malecek Michael JSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005083 · doc1.xml · derivative · entry 1 Malecek Michael J · CIK 0001779336 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Ordinary Shares · 56,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:09 UTC |
Walker Karin LChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001567619-21-005080 · doc1.xml · derivative · entry 1 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Ordinary Shares · 28,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 23:00 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 10,800 | $22.02 | $237,866.76 |
DisclosureSEC source: 0001567619-21-004963 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 10,159,280 F3 · shares: Qualified Fund purchased 9,067 of the Ordinary Shares purchased in this transaction. After this transaction, Qualified Fund owned 8,528,716 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 23:00 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 44,400 | $21.05 | $934,517.88 |
DisclosureSEC source: 0001567619-21-004963 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 10,148,480 F2 · shares: Qualified Fund purchased 37,274 of the Ordinary Shares purchased in this transaction. After this transaction, Qualified Fund owned 8,519,649 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 23:39 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,540 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-21-004526 · doc1.xml · derivative · entry 3 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,540 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · derivative.exercise_date: The shares subject to the option were fully vested as of the date of the exercise. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 23:39 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 7,540 | $25.50 | $192,270.00 |
DisclosureSEC source: 0001567619-21-004526 · doc1.xml · nonDerivative · entry 2 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 23:39 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 7,540 | $6.41 | $48,331.40 |
DisclosureSEC source: 0001567619-21-004526 · doc1.xml · nonDerivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:24 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 44,100 | $3.68 | $162,102.78 |
DisclosureSEC source: 0001567619-21-004588 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 10,104,080 F2 · shares: 37,022 of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,482,375 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 20:57 UTC Amendment |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 44,100 | $23.65 | $1,043,075.25 |
DisclosureSEC source: 0001567619-21-004660 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 10,104,080 F2 · shares: 37,022 of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,482,375 Ordinary Shares. F3 · price: The Filers are filing this amendment to correct the price at which the Ordinary Shares were purchased. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 00:14 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCall Option · Derivative | 2,500 | $3.68 Strike: $30.00 | $9,189.50 |
DisclosureSEC source: 0001567619-21-004320 · doc1.xml · derivative · entry 5 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 2,500 Underlying: Ordinary Shares · 250,000 shares Expires 2021-06-30 F6 · shares: 2,099 of the options purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 2,099 options to acquire 209,900 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 00:14 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 198,840 | $23.46 | $4,665,541.99 |
DisclosureSEC source: 0001567619-21-004320 · doc1.xml · nonDerivative · entry 4 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 10,059,980 F5 · shares: 166,926 of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,445,353 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 17, 2021 Filed Feb 26, 2021 21:09 UTC Amendment |
EcoR1 Capital, LLC10% owner
|
PurchaseCall Option · Derivative | 2,500 | $3.68 Strike: $30.00 | $9,189.50 |
DisclosureSEC source: 0001567619-21-005004 · doc1.xml · derivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 2,500 Underlying: Ordinary Shares · 250,000 shares Expires 2021-06-18 F2 · shares: 2,099 of the options purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 2,099 options to acquire 209,900 Ordinary Shares. F3 · derivative.expiration_date: The Filers are filing this amendment to correct the expiration date of the options, which was reported as 6/30/2021 in the Form 4 filed on 2/17/2021. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 00:14 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 89,200 | $22.78 | $2,031,967.08 |
DisclosureSEC source: 0001567619-21-004320 · doc1.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,861,140 F4 · shares: 80,040 of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,278,427 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
COLLIER RICHARD TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 6 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
COLLIER RICHARD TDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 5 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
COLLIER RICHARD TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 4 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
COLLIER RICHARD TDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
COLLIER RICHARD TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
COLLIER RICHARD TDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:47 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,750 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0001567619-21-004318 · doc1.xml · derivative · entry 6 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Ordinary Shares · 18,750 shares Expires 2029-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.